Logos Global Management LP Landos Biopharma, Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.44 - $5.22 $1.98 Million - $7.18 Million	-1,375,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.7 - $15.0 $141,000 - $450,000	-30,000 Reduced 2.14%	1,375,000 $6.6 Million
Q3 2021 Nov 15, 2021	BUY	$9.77 - $15.77 $4.94 Million - $7.98 Million	505,894 Added 56.27%	1,405,000 $20.5 Million
Q2 2021 Aug 16, 2021	BUY	$9.26 - $12.53 $1.53 Million - $2.07 Million	165,106 Added 22.49%	899,106 $10.4 Million
Q1 2021 May 17, 2021	BUY	$9.47 - $16.26 $6.95 Million - $11.9 Million	734,000 New	734,000 $7.07 Million

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.